In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression

Transfusion and Apheresis Science

Volumn 37, Issue 2, 2007, Pages 145-156

  Villaron, E M ^a,b   Almeida, J ^b   Lopez Holgado, N ^a,b   Sanchez Guijo, F M ^a,b   Alberca, M ^a,b   Blanco, B ^a,b   Sanchez Abarca, L I ^a,b   Lopez, O ^a,b   Perez Simon, J A ^a,b   San Miguel, J F ^a,b   del Canizo M C ^a,b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

CD34+ cells; Chemotherapy; Clonogenic assays; Immunophenotype; Non Hodgkin lymphoma

Indexed keywords

ANTIINFECTIVE AGENT; CD34 ANTIGEN; THY 1 ANTIGEN;

ADULT; AGED; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; IMMUNOPHENOTYPING; LEUKAPHERESIS; MALE; NONHODGKIN LYMPHOMA; STEM CELL;

ANTIGENS, CD34; ANTIGENS, THY-1; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD DONORS; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; LEUKAPHERESIS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 36549018971     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.05.001     Document Type: Article

References (43)

1. Philip T., Guglielmi C., Hagenbeek A., et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New Engl J Med 333 (1995) 1540-1545
2. Haioun C., Lepage E., Gisselbrecht C., et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe détude des lymphomas del'adulte. J Clin Oncol 15 (1997) 1131-1137
3. Gianni A.M., Bregni M., Siena S., et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. New Engl J Med 336 (1997) 1290-1297
4. Szilvassy S.J., Fraser C.C., Eaves C.J., et al. Retrovirus-mediated gene transfer to purified hematopoietic stem cells with long-term lympho-myelopoietic repopulating ability. Proc Natl Acad Sci USA 86 (1989) 8798-8802
5. Wolf N.S., Kone A., Priestley G.V., et al. In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection. Exp Hematol 21 (1993) 614-622
6. Morley A., and Blake J. An animal modelo f chronic aplastic marrow failure. I. Late marrow failure after busulfan. Blood 44 (1974) 49-56
7. Morley A., Trainor K., and Blake J. A primary stem cell lesion in experimental chronic hypoplastic marrow failure. Blood 45 (1975) 681-688
8. Botnick L.E., Hannon E.C., and Hellman S. Multisystem stem cell failure after apparent recovery from alkylating agents. Cancer Res 38 (1978) 1942-1947
9. Botnick L.E., Hannon E.C., and Hellman S. Limiting proliferation of stem cells surviving alkylating agents. Nature 262 (1976) 68-70
10. Botnick L.E., Hannon E.C., Vigneulle R., et al. Differential effects of cytotoxic agents on hematopoietic progenitors. Cancer Res 41 (1981) 2338-2342
11. Bensinger W., Appelbaum F., Rowley S., et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 13 (1995) 2547-2555
12. Haas R., Möhle R., Frühauf S., et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83 (1994) 3787-3794
13. Weaver C.H., Schwartzberg L.S., Birch R., et al. Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte colony-stimulating factor, an analysis of 497 patients. Transfusion 37 (1997) 896-903
14. Ketterer N., Salles G., Moullet I., et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 103 (1998) 235-242
15. Tricot G., Jagannath S., Vesole D., et al. Peripheral blood stem cells transplants for multiple myeloma: identification of favourable variables for rapid engraftment in 225 patients. Blood 85 (1995) 588-596
16. Gertz M.A., Lacy M.Q., Inwards D.J., et al. Factors influencing platelet recovery after blood cell transplantation in multiple myeloma. Bone Marrow Transpl 20 (1997) 375-380
17. Bonick L., Hannon E.C., and Hellman S. A long lasting proliferative defect in the hematopoietic stem cell compartment following cytotosic agents. Int J Radiat Oncol Biol Phys 5 (1979) 1621-1625
18. Mauch P., Down J., Warhol M., et al. Recipient preparation for bone marrow transplantation. I. Efficacy of total body irradiation and busulfan. Transplantation 46 (1988) 205-210
19. Abkowitz J.L., Linenberger M.L., Persik M., et al. Behaviour of feline hematopoietic stem cells years after busulfan exposure. Blood 82 (1993) 2096-2103
20. Hornung R.L., and Longo D.L. Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high dose cyclophosphamide therapy. Blood 80 (1992) 77-83
21. Neben S., Hellman S., Montgomery M., et al. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol 21 (1993) 156-162
22. Gardner R.V. Long term hematopoietic damage after chemotherapy and cytokine. Front Biosci 4 (1999) e47-e57 Review
23. Menendez P., del Cañizo M.C., and Orfao A. Immunophenotypic characteristics of PB-mobilised CD34+ hematopoietic progenitor cells. J Biol Regul Homeost Agents 15 (2001) 53-61
24. Mehta J., Powles R., Treleaven J., et al. Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: an important modifiable factor influencing outcome. Blood 90 (1997) 3808-3810
25. Menedez P., Prosper F., Bueno C., et al. Sequential analysis of CD34+ and CD34- in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide. Leukemia 15 (2000) 430-439
26. Mauch P., Constine L., Greenberger J., et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys 31 (1995) 1319
27. Damon L.E., Rugo H.S., Ries C.A., et al. Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukaemia. Leukemia 8 (1994) 535-541
28. Ploemacher R.E., Brockbank K.G.M., Brons R.H.C., et al. Latent sustained injury of hemopoietic organ stroma induced by ionising irradiation. Haematologica 68 (1983) 454-468
29. Del Cañizo M.C., Lopez N., Vazquez L., et al. Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery. Haematologica 84 (1999) 511-516
30. Menedez P., Caballero M.D., Prosper F., et al. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen. Transfusion 42 (2002) 1159-1172
31. Brendel C., and Neubauer A. Characteristics and analysis of normal and leukemic stem cells: current concepts and future directions. Leukemia 14 (2000) 1711-1717
32. Rusten L.S., Jacobsen S.E., Kaahuls O., et al. Functional differences between CD38- and DR- subfractions of CD34 bone marrow cells. Blood 84 (1994) 1473-1481
33. Huang S., and Terstappen L.W. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells. Blood 83 (1994) 1515-1526
34. Mayani H., and Lansdorp P.M. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 83 (1994) 2410-2417
35. Fritsch G., Stimplf M., Kurz M., et al. The composition of CD34 subpopulations differs between bone marrow blood and cord blood. Bone Marrow Transpl 17 (1996) 169-178
36. Meldgaard Knudsen L., Jensen L., Jarlbaek L., et al. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation. Haematologica 84 (1999) 517-524
37. Dercksen M.W., Rodenhuis S., Dirkson M.K., et al. Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation. J Clin Oncol 13 (1995) 1922-1932
38. del Cañizo C., Lopez N., Caballero D., et al. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation. Bone Marrow Transpl 23 (1999) 901-905
39. Benboubker L., Cartron G., Roingeard F., et al. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow. Exp Hematol 31 (2003) 89-97
40. Watts M.J., Sullivan A.M., Jamieson E., et al. Progenitor cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor cell quantity and quality and factors predictive for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol 15 (1997) 535-546
41. Moore M.A.S., Williams N., and Metcalf D. In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony forming cells. J Natl Cancer Inst 56 (1973) 603-623
42. Gordon M.Y. Human haematopoietic stem cell assays. Blood Rev 7 (1993) 190-197
43. To L.B., Haylock D.N., Kimber R.J., et al. High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation. Br J Haematol 58 (1984) 399-410